CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Medical Cannabis Use in Palliative Care: Clinical Effectiveness and Guidelines

Last updated: September 10, 2018
Project Number: RB1257-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of medical cannabis products for symptom control in adult palliative care patients?
  2. What are the evidence-based guidelines regarding medical cannabis products for symptom control in adult palliative care patients?

Key Message

Two systematic reviews (one with a meta-analysis), one non-randomized study, and two evidence-based guidelines were identified regarding medical cannabis products for symptom control in adult palliative care patients.